Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ

NCT06808971 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastro-esophageal Junction Adenocarcinoma

Interventions

DRUG: Adebrelimab, Nab-paclitaxel, Oxaliplatin, Tegafur Gimeracil Oteracil Potassium Capsule

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences